(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

P360

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

P360

ST13

US500000088775725

Classe

9, 42

Pedido

88775725

Registro

6214748

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

07/04/2026

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

28/01/2020

Data de registro

08/12/2020

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/04/2026

Última transação

07/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Primeiro uso

06/01/2020

Primeiro uso no comércio

06/01/2020

Código do desenho

4

Tipo de titular

03

Localização do titular

Edison, NJ, US

Examinador

LARKEY, MICHAEL M

Localização atual

Historical data usage

Titulares e representantes

Titulares

Optiks Solutions, Inc
Optiks Solutions, Inc

Representantes

Erin C Bray TRADEMARK LAWYER LAW FIRM, PLLC

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer software featuring computer software platforms for IT Solutions for HealthcareMedical Devicespharmaceutical and biotech industriesSales Force Automation to log interactions with health care professionalspatientshealthcare organizations including physiciansPatientsPayersProvidersCustomer Relationship Management application to manage ContactsAccountsOpportunitiesOrders and other custom entitiesMaintain operational customer master and integrate with other applicationsApplication to manage all phases of clinical trials including Site Management and Study ManagementApplication to provide patients with complete support during the course of therapy from the time of prescription including welcome callBenefit InvestigationsTrial OrdersPrior Authorization; downloadable Analytics and Planning software providing advanced analytics using machine learningInternet of Things (IoT)artificial intelligence to support interactions between pharma/biotech/med devices companiesphysicianspayersproviders; recorded Analytics and Planning software providing advanced analytics using machine learningInternet of Things (IoT)artificial intelligence to support interactions between pharma/biotech/med devices companiesphysicianspayersproviders

Classe 42

Platform as a service (PAAS) featuring computer software platforms for IT Solutions for HealthcareMedical Devicespharmaceutical and biotech industriesMobile Application to Record Interactions with Healthcare Professionalspatientshealthcare organizations Including PhysiciansPatientsPayersProviders and Providing Representatives an Ability to View Media Content and ReportsWeb and Mobile Portals For Patients to Find Information on Drugs and Connect with Pharma CompaniesWeb and Mobile Portals For Physicians to Find Information on Drugs and Connect with Pharma CompaniesMobile and Web Application to Providing Reporting and Analytics Capabilities Using Various Data Sources; Providing temporary use of non-downloadable cloud based software featuring computer software platforms for IT Solutions for HealthcareMedical Devices pharmaceutical and biotech industriesSales Force Automation to log interactions with health care professionals including physiciansPatientsPayersProvidersCustomer Relationship Management application to manage ContactsAccountsOpportunitiesOrders and other custom entitiesMaintain operational customer master and integrate with other applicationsApplication to manage all phases of clinical trials including Site Management and Study ManagementApplication to provide patients with complete support during the course of therapy from the time of prescription including welcome callBenefit InvestigationsTrial OrdersPrior Authorization; Providing temporary use of online non-downloadable Analytics and Planning software providing advanced analytics using machine learningInternet of Things (IoT)artificial intelligence to support interactions between pharmabiotechmed devices companiesphysicianspayersproviders; software as a service (SAAS) services featuring Analytics and Planning software providing advanced analytics using machine learningInternet of Things (IoT)artificial intelligence to support interactions between pharma/biotech/med devices companiesphysicianspayersproviders

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/04/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/04/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/04/2026

E815

TEAS SECTION 8 & 15 RECEIVED

13/01/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/12/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

25/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/06/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

25/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/12/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/09/2020

PUBO

PUBLISHED FOR OPPOSITION

22/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/09/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

19/08/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/08/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/08/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/08/2020

GNFR

FINAL REFUSAL E-MAILED

04/08/2020

CNFR

FINAL REFUSAL WRITTEN

04/08/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/05/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/05/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

19/05/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/05/2020

GNRT

NON-FINAL ACTION E-MAILED

03/05/2020

CNRT

NON-FINAL ACTION WRITTEN

03/05/2020

DOCK

ASSIGNED TO EXAMINER

16/04/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2020

NWAP

NEW APPLICATION ENTERED

31/01/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace P360 ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.